HEalth Advocate for Liver Transplant - Pilot
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 15
- 试验地点
- 1
- 主要终点
- Changes in caregiver experience
研究概览
简要总结
The Health Advocate for Liver Transplant (HEAL-Tx) Pilot is a nonrandomized, open-label intervention pilot of a health advocate intervention aimed to assess feasibility and acceptability of integrating a Health Advocate onto the transplant team. Across studies, health advocate roles vary, and can include coordinating medical care treatment, facilitating financial assistance (e.g., taxi vouchers), and connecting patients to community resources, which can improve self-management, mitigate social risks, and lead to better communication between the healthcare system and the family. In this pilot, the investigators will adapt this intervention for pediatric liver transplant patients and measure acceptability and feasibility according to RE-AIM.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Supportive Care
- 盲法
- None
入排标准
- 年龄范围
- — 至 17 Years（Child）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients under 18 years if age that have undergone liver transplantation.
- •Subject and/or parent/legal guardian can provide written informed consent and willing to comply with study procedures.
- •Subject and/or parent/ legal guardian is willing to be contacted in the future by study staff.
- •Patient and/or caregiver felt to be a good fit for this pilot by transplant team.
排除标准
- •Caregiver unwilling or unable to complete the survey.
- •Child is a ward of the state (e.g. foster care) since present circumstances may not be reflective of child's past or future circumstances.
- •Non-English, non-Spanish speakers.
- •Non-US residents.
- •Greater than 18 years of age at the time of enrollment.
研究组 & 干预措施
Intervention
This is a single arm pilot intervention.
干预措施: Health Advocate (Behavioral)
结局指标
主要结局
Changes in caregiver experience
时间窗: Baseline and 90 days
The investigators will administer a survey of caregiver experiences at study enrollment and at the end of the intervention to assess for changes in caregiver experience with the transplant team. These questions will focus on experiences receiving transplant care, experiences discussing social needs with the transplant team, and overall caregiver subjective assessment of the transplant recipient's overall health.
次要结局
- Change in medication adherence using MLVI(Baseline, 90 days, and 180 days)
- The quality of health advocate interactions with the participants, healthcare team, and community-based resources.(90 days)
- A qualitative assessment of caregiver and healthcare provider satisfaction with the Health Advocate intervention.(90 days)